<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; IMGN</title>
	<atom:link href="http://www.stockbloghub.com/tag/imgn/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(CNW) Company News for July 7, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/07/07/cnw-company-news-for-july-7-2011-corporate-summary/78551</link>
		<comments>http://www.stockbloghub.com/2011/07/07/cnw-company-news-for-july-7-2011-corporate-summary/78551#comments</comments>
		<pubDate>Thu, 07 Jul 2011 17:02:41 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Services]]></category>
		<category><![CDATA[Trucking]]></category>
		<category><![CDATA[Cepheid]]></category>
		<category><![CDATA[CNW]]></category>
		<category><![CDATA[Con-Way Inc.]]></category>
		<category><![CDATA[CPHD]]></category>
		<category><![CDATA[Ener1 Inc.]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[HEV]]></category>
		<category><![CDATA[HTCH]]></category>
		<category><![CDATA[Hutchinson Technology Inc]]></category>
		<category><![CDATA[IMGN]]></category>
		<category><![CDATA[Immunogen Inc]]></category>
		<category><![CDATA[KCI]]></category>
		<category><![CDATA[Kinetic Concepts Inc]]></category>
		<category><![CDATA[PHMD]]></category>
		<category><![CDATA[PhotoMedex Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78551</guid>
		<description><![CDATA[•    Share prices of disk-drive components suppliers Hutchinson Technology Inc. (NASDAQ:HTCH) shot up by 21.15% after the company said it is optimistic about posting  higher-than-expected third quarter earnings results •    Shares of drug developer ImmunoGen, Inc. (NASDAQ:IMGN)  gained 9.50%  after analysts at  Jefferies initiated coverage on the company with a &#8220;Buy&#8221; rating •    According to reports from Bloomberg and New York Times, Kinetic Concepts (NYSE:KCI)  which provides wound healing technology is planning to go private in a leveraged buyout •    Skin-care products manufacturer PhotoMedex Inc. (NASDAQ:PHMD) announced plans to buy rival Radiancy Inc. for $174 million in stock in a reverse merger. The deal will help PhotoMedex to grow and expand Radiancy&#8217;s hair removal kit market •    U.S. listed share prices of Canadian telecom-equipment maker DragonWave, Inc. (NASDAQ:DRWI)  declined by ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/07/cnw-company-news-for-july-7-2011-corporate-summary/78551/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AER) Company News for April 11, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/04/11/aer-company-news-for-april-11-2011-corporate-summary/71176</link>
		<comments>http://www.stockbloghub.com/2011/04/11/aer-company-news-for-april-11-2011-corporate-summary/71176#comments</comments>
		<pubDate>Mon, 11 Apr 2011 21:01:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Rental & Leasing Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AER]]></category>
		<category><![CDATA[AerCap Holdings N.V.]]></category>
		<category><![CDATA[Bally Technologies Inc.]]></category>
		<category><![CDATA[Beacon Roofing Supply Inc.]]></category>
		<category><![CDATA[BECN]]></category>
		<category><![CDATA[BJ]]></category>
		<category><![CDATA[BJ's Wholesale Club Inc.]]></category>
		<category><![CDATA[BYI]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[COST]]></category>
		<category><![CDATA[Costco Wholesale Corporation]]></category>
		<category><![CDATA[EXPE]]></category>
		<category><![CDATA[Expedia Inc.]]></category>
		<category><![CDATA[F5 Networks Inc.]]></category>
		<category><![CDATA[FFIV]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[IMGN]]></category>
		<category><![CDATA[Immunogen Inc]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Nabors Industries Limited]]></category>
		<category><![CDATA[NBR]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71176</guid>
		<description><![CDATA[• Google (NASDAQ:GOOG) agreed to enter into a consent decree with the Justice Department with regard to its purchase of ITA Software Inc. The company will be subject to compulsory licensing and government monitoring of travel search and services. Google will have to impose firewalls on client data • Johnson &#38; Johnson (NYSE:JNJ) announced it will pay $70 million in fines, disgorgement and interest in a settlement related to publicly disclosed Foreign Corrupt Practices Act investigations by the Justice Department and the SEC. As part of the settlement, the company has entered into a Deferred Prosecution Agreement with the DOJ and a Consent to Final Judgment with the SEC • Expedia (NASDAQ:EXPE) announced plans to spin off its TripAdvisor unit into a separate, publicly traded company. Under the proposed deal, the company would ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/11/aer-company-news-for-april-11-2011-corporate-summary/71176/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GSK) Company News for April 08, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/04/08/gsk-company-news-for-april-08-2011-corporate-summary/71030</link>
		<comments>http://www.stockbloghub.com/2011/04/08/gsk-company-news-for-april-08-2011-corporate-summary/71030#comments</comments>
		<pubDate>Fri, 08 Apr 2011 17:21:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[BBBY]]></category>
		<category><![CDATA[Bed Bath & Beyond Inc.]]></category>
		<category><![CDATA[Coinstar Inc.]]></category>
		<category><![CDATA[Constellation Brands Inc.]]></category>
		<category><![CDATA[CRM]]></category>
		<category><![CDATA[CSTR]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[IMGN]]></category>
		<category><![CDATA[Immunogen Inc]]></category>
		<category><![CDATA[Lam Research Corporation]]></category>
		<category><![CDATA[LRCX]]></category>
		<category><![CDATA[Pier 1 Imports Inc.]]></category>
		<category><![CDATA[PIR]]></category>
		<category><![CDATA[Salesforce.com]]></category>
		<category><![CDATA[STZ]]></category>
		<category><![CDATA[Xenoport Inc]]></category>
		<category><![CDATA[XNPT]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71030</guid>
		<description><![CDATA[• Bed Bath &#38; Beyond Inc.’s (NASDAQ:BBBY) shares rose 10.5% a day after the retailer projected earnings ahead of Wall Street’s expectations for the fiscal year ending in Feb. 2012 • Drug developer Immunogen Inc. (NASDAQ:IMGN) reported positive results from a mid-stage study of its breast-cancer treatment • Home-furnishing retailer Pier 1 Imports Inc (NYSE:PIR) reported better-than-expected profit and sales for the fourth quarter and announced plans to buy back up to $100 million in stock • Late Wednesday, XenoPort Inc. (NASDAQ:XNPT) and GlaxoSmithKline PLC (GSK) announced that they had received regulatory approval for a drug to treat restless-legs syndrome • Citigroup analysts added semiconductor equipment maker, Lam Research Corp (NASDAQ:LRCX) to the brokerage’s conviction sell list • Wine and spirits maker Constellation Brands (NYSE:STZ) forecasts its full-year profit above the Street&#8217;s view and announced a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/08/gsk-company-news-for-april-08-2011-corporate-summary/71030/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GOOG) Two Stocks Set to Benefit As Healthcare Goes Digital</title>
		<link>http://www.stockbloghub.com/2011/02/02/goog-two-stocks-set-to-benefit-as-healthcare-goes-digital/65192</link>
		<comments>http://www.stockbloghub.com/2011/02/02/goog-two-stocks-set-to-benefit-as-healthcare-goes-digital/65192#comments</comments>
		<pubDate>Wed, 02 Feb 2011 15:11:35 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Internet Information Providers]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[IMGN]]></category>
		<category><![CDATA[Immunogen Inc]]></category>
		<category><![CDATA[Lexicon Pharmaceuticals Inc]]></category>
		<category><![CDATA[LXRX]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[Seattle Genetics Inc]]></category>
		<category><![CDATA[SGEN]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=65192</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U’s Healthcare Specialist Friday, January 14, 2011: Issue #1428 Editor’s Note: To round off the week, our resident healthcare expert, Marc Lichtenfeld, brings you his second and final report from the J.P. Morgan Healthcare Conference in San Francisco. If you read yesterday’s column, you’ll known that Marc has identified three key trends for the sector this year – one, healthcare reform; two, the “patent cliff” and three… well, take a look below to find out… Talk about an all-star panel of high-tech heavyweights… As I filed into the room, the stage boasted: Aneesh Chopra, the United States’ Chief Technology Officer. Todd Park, Chief Technology Officer at the Department of Health &#38; Human Services. Eric Schmidt, Chairman and CEO of Google (Nasdaq: GOOG). They were there for ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/02/goog-two-stocks-set-to-benefit-as-healthcare-goes-digital/65192/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ASH) Investing in the Biotech Sector: Here’s An Easy Way to Profit from Biotech Stocks</title>
		<link>http://www.stockbloghub.com/2009/11/11/ash-investing-in-the-biotech-sector-here%e2%80%99s-an-easy-way-to-profit-from-biotech-stocks/20305</link>
		<comments>http://www.stockbloghub.com/2009/11/11/ash-investing-in-the-biotech-sector-here%e2%80%99s-an-easy-way-to-profit-from-biotech-stocks/20305#comments</comments>
		<pubDate>Wed, 11 Nov 2009 21:51:36 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Basic Materials]]></category>
		<category><![CDATA[Chemicals - Major Diversified]]></category>
		<category><![CDATA[ARIA]]></category>
		<category><![CDATA[Ariad Pharmaceuticals Inc]]></category>
		<category><![CDATA[ASH]]></category>
		<category><![CDATA[Ashland Inc.]]></category>
		<category><![CDATA[Biomarin Pharmaceutical Inc]]></category>
		<category><![CDATA[BMRN]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[CELG]]></category>
		<category><![CDATA[Celgene Corporation]]></category>
		<category><![CDATA[IMGN]]></category>
		<category><![CDATA[Immunogen Inc]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[PARD]]></category>
		<category><![CDATA[Poniard Pharmaceuticals Inc]]></category>
		<category><![CDATA[SuperGen Inc]]></category>
		<category><![CDATA[SUPG]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=20305</guid>
		<description><![CDATA[by Marc Lichtenfeld, Healthcare Expert Wednesday, November 11, 2009: Issue #1135 Investing in the biotech sector can be risky – no doubt about that. But you know what? There are a lot of ways to make money from biotech stocks, too. If you know what to look for, that is. Two obvious examples include: Picking the company behind the next breakthrough drug for cancer or Alzheimer’s. Digging out companies that are likely takeover targets (something my colleague Louis Basenese does expertly in his Takeover Trader service), or landing lucrative drug partnership deals, which send the stocks higher. But there’s another excellent way that shorter-term investors can grab gains and profit from biotech sector… Follow the Biotech Sector Conference Buzz Throughout the year, the biotech sector holds many key conferences where ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/11/ash-investing-in-the-biotech-sector-here%e2%80%99s-an-easy-way-to-profit-from-biotech-stocks/20305/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(IMGN) Amgen Taps ImmunoGen License</title>
		<link>http://www.stockbloghub.com/2009/09/18/amgn-amgen-taps-immunogen-license/15555</link>
		<comments>http://www.stockbloghub.com/2009/09/18/amgn-amgen-taps-immunogen-license/15555#comments</comments>
		<pubDate>Fri, 18 Sep 2009 17:25:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Amgen]]></category>
		<category><![CDATA[AMGN]]></category>
		<category><![CDATA[IMGN]]></category>
		<category><![CDATA[Immunogen Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=15555</guid>
		<description><![CDATA[Yesterday, ImmunoGen Inc. (IMGN) announced that it has licensed its technology to Amgen Inc. (AMGN) to develop anticancer drugs. The deal allows Amgen exclusive rights to use ImmunoGen’s maytansinoid targeted antibody payload [TAP] technology for developing anticancer therapeutics to an undisclosed target found on solid tumors. According to the terms of the deal, ImmunoGen will receive $1 million in an upfront license payment. Furthermore, it is entitled to receive milestone payments of up to $34 million coupled with royalties on the sales of any resulting products. The responsibility for the development, manufacturing and marketing of any products resulting from the deal lies with Amgen. This license was taken under an agreement established in September 2000 between ImmunoGen and Abgenix, Inc. The latter has since been acquired by Amgen. The agreement ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/09/18/amgn-amgen-taps-immunogen-license/15555/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

